ANA773

Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Roche
Anadys
hepatitis C
ANA773
Abbott Laboratories